透過您的圖書館登入
IP:3.238.71.155
  • Journals
  • OpenAccess

Tumor Target: Friend or Foe?

Abstracts


Cancer metastasis, resistance to treatment, and relapse are major issues faced by patients with cancer. Research on cancer relapse is ongoing. Tumors are becoming resistant to traditional chemotherapy, targeted therapy, and immunotherapy. The problem resides at the cancer cell receptors. Receptors are small pockets that can sometimes be blocked with small targeted molecules, sensitive to traditional chemotherapy, or more complex ones that require checkpoint inhibitor antibodies in immune-oncology treatment. Each scenario has its own implications for the clinical benefit of patients. This short communication examines the various cancer settings and their relation to drug sensitivities of receptors with the aim of finding solutions to the problem of distinguishing between friends and foes in novel cancer treatments.

Read-around